Reply to L. Cabel et al

Affiliations

¹ Kaiser Permanente Vallejo Medical Center, Kaiser Permanente Northern California, Vallejo, CA Lou.fehrenbacher@kp.org.
² Kaiser Permanente Northern California, Oakland, CA.

Comment

Louis Fehrenbacher et al. J Clin Oncol. 2015.

. 2015 Jan 20;33(3):292-3.

doi: 10.1200/JCO.2014.58.9671. Epub 2014 Dec 15.

¹ Kaiser Permanente Vallejo Medical Center, Kaiser Permanente Northern California, Vallejo, CA Lou.fehrenbacher@kp.org.
² Kaiser Permanente Northern California, Oakland, CA.

No abstract available

Comment on

Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system.
Fehrenbacher L, Capra AM, Quesenberry CP Jr, Fulton R, Shiraz P, Habel LA. Fehrenbacher L, et al. J Clin Oncol. 2014 Jul 10;32(20):2151-8. doi: 10.1200/JCO.2013.52.0858. Epub 2014 Jun 2. J Clin Oncol. 2014. PMID: 24888815
Prognosis of t1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas.
Cabel L, Péron J, Cottu PH, Rodrigues MJ. Cabel L, et al. J Clin Oncol. 2015 Jan 20;33(3):291. doi: 10.1200/JCO.2014.58.6941. Epub 2014 Dec 15. J Clin Oncol. 2015. PMID: 25512462 No abstract available.